News for Adaptimmune Therapeutics plc (ADAP)

On December 31, 2024, Two Seas Capital LP (Trades, Portfolio) executed a noteworthy transaction by acquiring 89,010,876 shares of Adaptimmune Therapeutics PLC.

Significant Transaction by Baillie Gifford (Trades, Portfolio) On December 31, 2024, Baillie Gifford (Trades, Portfolio) executed a noteworthy transaction by si

Adaptimmune therapeutics' chief medical officer sells $3,243 in stock

Adaptimmune therapeutics CEO Adrian Rawcliffe sells shares worth $34,639

Adaptimmune's chief commercial officer sells $7,467 in shares

November 14, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform covering biotech and medical technology sto...

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ETCompany ParticipantsDan Od-Cohen - IRAdrian...

Adaptimmune faces Nasdaq delisting over share price

The key factors that boost the Cancer Gene Therapy Market growth are an increase in funding of R&D in the activities of cancer gene therapy along with the...

Westford, USA, Sept. 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Gene Therapy Market will reach a value of USD 38.34 Billion by 2031,...

“Tumour-Infiltrating Lymphocyte (TIL) Therapy Market” from 2024-2034 with covered segments By Therapy Type (Autologous TIL Therapy, Allogeneic TIL...

August 12, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform covering biotech and medical technology issues a snapshot on recent n...

Adaptimmune Reports Q2 2024 Financial and Business Updates

Shares of Ainos, Inc. AIMD rose sharply in today's pre-market trading after the company announced that it has obtained exclusive licenses for a total of 10 inve...

Loading... Loading... Shares of SentinelOne, Inc. S shares fell sharply during Friday's session after the company posted mixed first-quarter results. Sentinel...

Loading... Loading... Shares of Zscaler, Inc. ZS rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter earni...

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

California-based skincare development company Elevai Labs, Inc. (ELAB) is up over 94 percent in Thursday's pre-market trading. The following are some of the stocks making big moves in Thursday's pre-market trading.

Acumen Research and Consulting recently published report titled “Autologous Cell Therapy Market Forecast, 2023 - 2032”...